These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32418846)

  • 1. Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial.
    Kim BJ; Hunter A; Brucker AJ; Hahn P; Gehrs K; Patel A; Edwards AO; Li Y; Khurana RN; Nissim I; Daniel E; Grunwald J; Ying GS; Pistilli M; Maguire MG; Dunaief JL
    Ophthalmol Retina; 2020 Sep; 4(9):889-898. PubMed ID: 32418846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
    Rosenfeld PJ; Dugel PU; Holz FG; Heier JS; Pearlman JA; Novack RL; Csaky KG; Koester JM; Gregory JK; Kubota R
    Ophthalmology; 2018 Oct; 125(10):1556-1567. PubMed ID: 29716784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegcetacoplan Treatment and Consensus Features of Geographic Atrophy Over 24 Months.
    Fu DJ; Bagga P; Naik G; Glinton S; Faes L; Liefers B; Lima R; Wignall G; Keane PA; Ioannidou E; Ribeiro Reis AP; McKeown A; Scheibler L; Patel PJ; Moghul I; Pontikos N; Balaskas K
    JAMA Ophthalmol; 2024 Jun; 142(6):548-558. PubMed ID: 38722644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
    Heier JS; Pieramici D; Chakravarthy U; Patel SS; Gupta S; Lotery A; Lad EM; Silverman D; Henry EC; Anderesi M; Tschosik EA; Gray S; Ferrara D; Guymer R;
    Ophthalmol Retina; 2020 Jul; 4(7):673-688. PubMed ID: 32199866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
    Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG
    Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
    Holz FG; Sadda SR; Busbee B; Chew EY; Mitchell P; Tufail A; Brittain C; Ferrara D; Gray S; Honigberg L; Martin J; Tong B; Ehrlich JS; Bressler NM;
    JAMA Ophthalmol; 2018 Jun; 136(6):666-677. PubMed ID: 29801123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study.
    Heier JS; Ho AC; Samuel MA; Chang T; Riemann CD; Kitchens JW; Slakter JS; Leiderman YI; Spencer R; Williams GA; Hickson-Curran SB; Keane M; Baldassarre JS;
    Ophthalmol Retina; 2020 Apr; 4(4):384-393. PubMed ID: 32033908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of Topographic Distribution of Geographic Atrophy to Visual Acuity in Nonexudative Age-Related Macular Degeneration.
    Shen LL; Sun M; Ahluwalia A; Young BK; Park MM; Toth CA; Lad EM; Del Priore LV
    Ophthalmol Retina; 2021 Aug; 5(8):761-774. PubMed ID: 33212271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.
    Domalpally A; Danis R; Agrón E; Blodi B; Clemons T; Chew E;
    Ophthalmology; 2016 Nov; 123(11):2401-2407. PubMed ID: 27448832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
    Jaffe GJ; Westby K; Csaky KG; Monés J; Pearlman JA; Patel SS; Joondeph BC; Randolph J; Masonson H; Rezaei KA
    Ophthalmology; 2021 Apr; 128(4):576-586. PubMed ID: 32882310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study.
    Yehoshua Z; de Amorim Garcia Filho CA; Nunes RP; Gregori G; Penha FM; Moshfeghi AA; Zhang K; Sadda S; Feuer W; Rosenfeld PJ
    Ophthalmology; 2014 Mar; 121(3):693-701. PubMed ID: 24289920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Human Central Nervous System Stem Cell Subretinal Transplantation on Progression of Geographic Atrophy Secondary to Nonneovascular Age-Related Macular Degeneration.
    Nittala MG; Uji A; Velaga SB; Hariri AH; Naor J; Birch DG; Spencer R; Leng T; Capela A; Tsukamoto A; Ip M; Sadda SR
    Ophthalmol Retina; 2021 Jan; 5(1):32-40. PubMed ID: 32562884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Brader HS; Ying GS; Martin ER; Maguire MG;
    Ophthalmology; 2013 Sep; 120(9):1871-9. PubMed ID: 23622873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 Trial Evaluating Minocycline for Geographic Atrophy in Age-Related Macular Degeneration: A Nonrandomized Controlled Trial.
    Keenan TDL; Bailey C; Abraham M; Orndahl C; Menezes S; Bellur S; Arunachalam T; Kangale-Whitney C; Srinivas S; Karamat A; Nittala M; Cunningham D; Jeffrey BG; Wiley HE; Thavikulwat AT; Sadda S; Cukras CA; Chew EY; Wong WT
    JAMA Ophthalmol; 2024 Apr; 142(4):345-355. PubMed ID: 38483382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study).
    Gillies MC; Hunyor AP; Arnold JJ; Guymer RH; Wolf S; Pecheur FL; Munk MR; McAllister IL
    Ophthalmology; 2020 Feb; 127(2):198-210. PubMed ID: 31619357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic Atrophy Growth Is Strongly Related to Lesion Perimeter: Unifying Effects of Lesion Area, Number, and Circularity on Growth.
    Shen LL; Sun M; Ahluwalia A; Young BK; Park MM; Del Priore LV
    Ophthalmol Retina; 2021 Sep; 5(9):868-878. PubMed ID: 33307218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.
    Petrou PA; Cunningham D; Shimel K; Harrington M; Hammel K; Cukras CA; Ferris FL; Chew EY; Wong WT
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):330-8. PubMed ID: 25525171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Kuppermann BD; Patel SS; Boyer DS; Augustin AJ; Freeman WR; Kerr KJ; Guo Q; Schneider S; López FJ;
    Retina; 2021 Jan; 41(1):144-155. PubMed ID: 32134802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.